Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Audit (A-03-08-00011)

Review of Medicare Part D Drug Payments to Baron Drug Company for Service Dates January 1 – March 31, 2006

Executive Summary

Baron Drug Company received improper payments of at least $79,000 from New Jersey, which the Centers for Medicare & Medicaid Services reimbursed under the “Reimbursement of State Costs for Provision of Part D Drugs” Medicare demonstration project.

Complete Report

Download the complete report (PDF)

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201